Camp4 Therapeutics CAMP
NASDAQ CAMP
$3.91 +0.06 (+1.56%)
At close: Sep 29, 2026 · 4:00 PM EDT

Camp4 Therapeutics (CAMP) Current Leases (2023 - 2025)

Updated

Camp4 Therapeutics (CAMP) recorded Current Leases of $27,000 in Q3 2025, down 84.1% from $170,000 a year earlier but up 3.8% from the prior quarter.

Analysis

Camp4 Therapeutics (CAMP) Current Leases (2023 - 2025) Analysis & Trends

At the end of FY2024, Camp4 Therapeutics reported Current Leases of $91,000, down 74.3% from FY2023.

  • Across earlier years, Current Leases came in at $354,000 in FY2023.
  • Quarterly Current Leases has ranged from $26,000 in Q2 2025 to $354,000 in Q4 2023 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $26,000 (Q2 2025), $43,000 (Q1 2025) and $91,000 (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 274.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -2.32 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Camp4 Therapeutics 199.92 Mn 199.92 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 27,000.00
Jun 30, 2025 26,000.00
Mar 31, 2025 43,000.00
Dec 31, 2024 91,000.00
Sep 30, 2024 170,000.00
Dec 31, 2023 354,000.00
API Access

Camp4 Therapeutics Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=CAMP&period=max&api_key=YOUR_API_KEY